跳至主要内容
临床试验/CTRI/2022/03/041539
CTRI/2022/03/041539尚未招募不适用

Study on levels of the Th17 and Treg pathway cytokines in Type 1 leprosy reactions

ABVIMS and Dr RML Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年8月4日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Levels of cytokine of Th 17 and Treg pathway in skin and blood of patients presenting with Type 1 leprosy reactions

研究概览

简要总结

To measure the levels of cytokines of Th17 and Treg pathway in skin and blood of patients presenting with type 1 leprosy reactions.

To compare with levels in non reactional leprosy patients

To reassess the levels of the cytokines following resolution of the reaction

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • 1.Adult Patients of either sex with Untreated recent Type 1 leprosy reaction, irrespective of MDT status 2.Presence of skin signs of Type 1 Leprosy reaction, with or without neuritis/ nerve function impairment.

排除标准

  • Those already on treatment for Type 1 reaction <18 Years of age Immunosuppressed patients- by way of disease or drugs Pregnancy and lactating females Presence of any other chronic illness.

结局指标

主要结局

Levels of cytokine of Th 17 and Treg pathway in skin and blood of patients presenting with Type 1 leprosy reactions

时间窗: Baeline and after resolution of reaction

次要结局

  • To measure levels of cytokines of Th17 and Treg pathway in non reactional leprosy patients(Baseline)

研究者

发起方
ABVIMS and Dr RML Hospital
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验